A PTK7-targeted antibody-drug conjugate reduces tumor-initiating cells and induces sustained tumor regressions.
about
PTK7 Faces the Wnt in Development and Disease.Canonical and non-canonical WNT signaling in cancer stem cells and their niches: Cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review)Recent Developments in ADC Technology: Preclinical Studies Signal Future Clinical Trends.Antibody-drug conjugate targeting protein tyrosine kinase 7, a receptor tyrosine kinase-like molecule involved in WNT and vascular endothelial growth factor signaling: effects on cancer stem cells, tumor microenvironment and whole-body homeostasis.SNCA Is a Functionally Low-Expressed Gene in Lung Adenocarcinoma.Harnessing BET Inhibitor Sensitivity Reveals AMIGO2 as a Melanoma Survival Gene.Gene annotation bias impedes biomedical research.Biphasic regulation of tumorigenesis by PTK7 expression level in esophageal squamous cell carcinoma.Immunotherapeutic interventions of Triple Negative Breast Cancer.Drug conjugates—an emerging approach to treat breast cancer.Periostin secreted by cancer-associated fibroblasts promotes cancer stemness in head and neck cancer by activating protein tyrosine kinase 7Long non-coding RNA DSCR8 acts as a molecular sponge for miR-485-5p to activate Wnt/β-catenin signal pathway in hepatocellular carcinoma
P2860
Q42243217-E06D41FA-83B6-4C4F-B1E2-4A077F3C4880Q42378297-A342A6C1-D527-492D-80C5-5C5DA488A8F1Q45728543-E5E9569E-1E0D-4743-8FAF-454B0C05AEF5Q47112549-45671395-23E6-4D12-A337-1EFBF2DBF42DQ47210545-B0528F2A-A7BE-48D7-BE6D-0A68975333C1Q47391313-C4F5CD12-2452-4B4B-8925-D5927BE9170BQ48190150-9F1EF94B-E294-4E43-B3F5-EE1C5854BF03Q54977102-83EB1220-53DD-47BB-A0A0-08B1284856D0Q55257180-21BFCB45-1F31-4E35-99B0-2ED53186B9C1Q55438401-5A227FA1-F022-480D-9623-FF166B61FA9BQ57801748-5A95675C-0E6D-4C4C-835B-17EDDC2AD6E3Q58699397-78B0D2E7-9B63-4309-B029-8736A3A76CD5
P2860
A PTK7-targeted antibody-drug conjugate reduces tumor-initiating cells and induces sustained tumor regressions.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
A PTK7-targeted antibody-drug ...... s sustained tumor regressions.
@en
A PTK7-targeted antibody-drug ...... s sustained tumor regressions.
@nl
type
label
A PTK7-targeted antibody-drug ...... s sustained tumor regressions.
@en
A PTK7-targeted antibody-drug ...... s sustained tumor regressions.
@nl
prefLabel
A PTK7-targeted antibody-drug ...... s sustained tumor regressions.
@en
A PTK7-targeted antibody-drug ...... s sustained tumor regressions.
@nl
P2093
P2860
P1476
A PTK7-targeted antibody-drug ...... s sustained tumor regressions.
@en
P2093
Albert Park
Alexander Bankovich
Alison Betts
Christina Lee
Christopher J O'Donnell
Edward Rosfjord
Elana Ernstoff
Frank Barletta
Hadi Falahatpisheh
P2860
P356
10.1126/SCITRANSLMED.AAG2611
P407
P577
2017-01-01T00:00:00Z